{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:19:06Z","timestamp":1792545546476,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eplepsyres.2021.106829","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:36:43Z","timestamp":1637879803000},"page":"106829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Impact of carbamazepine on vitamin D levels: A meta-analysis"],"prefix":"10.1016","volume":"178","author":[{"given":"Carla","family":"LoPinto-Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106829_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/2249-4863.192338","article-title":"Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies","volume":"5","author":"Arora","year":"2016","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","author":"Ascherio","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1528-1157.2003.44802.x","article-title":"Lipoprotein(a) concentration increases during treatment with carbamazepine","volume":"44","author":"Bramswig","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12610","article-title":"Vitamin D immunoregulation through dendritic cells","author":"Bscheider","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib8","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/nutrit\/nuaa092","article-title":"The implications of vitamin D deficiency on COVID-19 for at-risk populations","volume":"79","author":"DeLuccia","year":"2021","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105751","article-title":"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study","volume":"203","author":"Entrenas Castillo","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib12","first-page":"933","article-title":"Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid","volume":"13","author":"Erbayat Altay","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/epi.13586","article-title":"Medication adherence in women with epilepsy who are planning pregnancy","volume":"57","author":"Ernst","year":"2016","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2021.106829_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yebeh.2003.11.026","article-title":"Pathophysiology of bone loss in patients receiving anticonvulsant therapy","volume":"5","author":"Fitzpatrick","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02939839","article-title":"Factors associated with the biochemical changes in vitamin D and calcium metabolism in institutionalized patients with epilepsy","volume":"155","author":"Gough","year":"1986","journal-title":"Ir. J. Med Sci."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM197211022871803","article-title":"Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults","volume":"287","author":"Hahn","year":"1972","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","article-title":"The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy","volume":"52","author":"Heo","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1984.tb00806.x","article-title":"Carbamazepine and bone mineral metabolism","volume":"70","author":"Hoikka","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpem-2006-190411","article-title":"Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3","volume":"19","author":"Kumandas","year":"2006","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000177590","article-title":"Vitamin D status of ambulatory and nonambulatory mentally retarded children with and without carbamazepine treatment","volume":"34","author":"Lamberg-Allardt","year":"1990","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","article-title":"A review of the effect of anticonvulsant medications on bone mineral density and fracture risk","volume":"8","author":"Lee","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","author":"LoPinto-Khoury","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jn\/nxaa332","article-title":"Vitamin D deficiency is inversely associated with COVID-19 incidence and disease severity in chinese people","volume":"151","author":"Luo","year":"2021","journal-title":"J. Nutr."},{"issue":"Suppl 8","key":"10.1016\/j.eplepsyres.2021.106829_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2009.02235.x","article-title":"Should enzyme-inducing antiepileptic drugs be considered first-line agents?","volume":"50","author":"Mintzer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine","volume":"47","author":"Mintzer","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib27","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly","volume":"59","author":"Mintzer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106216","article-title":"Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy","volume":"158","author":"Mintzer","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pediatrneurol.2010.05.013","article-title":"Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children","volume":"43","author":"Misra","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jmv.26360","article-title":"Vitamin D insufficiency as a potential culprit in critical COVID\u201019 patients","volume":"93","author":"Munshi","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0074-7742(08)00018-4","article-title":"Bone health in women with epilepsy: clinical features and potential mechanisms","volume":"83","author":"Pack","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.20378","article-title":"Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy","volume":"57","author":"Pack","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/bcpt.12996","article-title":"A cross-sectional study to assess the modulation of Wnt inhibitors following anti-epileptic drug therapy and their correlation with vitamin D and receptor activator of nuclear factor kappa B ligand in indian women with epilepsy","volume":"123","author":"Parveen","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib34","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/epi.12162","article-title":"Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy","volume":"54","author":"Phabphal","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.4.5727.73","article-title":"Disturbance of calcium metabolism by anticonvulsant drugs","volume":"4","author":"Richens","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib36","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yebeh.2015.06.025","article-title":"The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine","volume":"51","author":"Serin","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bmj.4.5831.9","article-title":"Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs","volume":"4","author":"Stamp","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","article-title":"Low vitamin D levels are common in patients with epilepsy","volume":"108","author":"Teagarden","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0404.1983.tb04854.x","article-title":"Effect of vitamin D2 and D3 on bone\u2010mineral content in carbamazepine\u2010treated epileptic patients","volume":"68","author":"Tjellesen","year":"1983","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/epi.13993","article-title":"Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: a phase III double-blind, randomized, parallel-group, multicenter study","volume":"59","author":"Trinka","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib43","first-page":"16","article-title":"An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests","volume":"45","author":"Turan","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","article-title":"Increased bone turnover in epileptic patients treated with carbamazepin","volume":"47","author":"Verrotti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib45","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","article-title":"Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine","volume":"43","author":"Verrotti","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106829_bib46","unstructured":"Wells GA, Shea B., O\u2019Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: URL: \u3008http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm\u3009 [cited 2019]."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib47","first-page":"1","article-title":"Effect of carbamazepine on the bone health of people with epilepsy: a systematic review and meta-analysis","volume":"48","author":"Zhang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.eplepsyres.2021.106829_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1631\/jzus.B1500021","article-title":"Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis","volume":"16","author":"Zhang","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:49:45Z","timestamp":1760276985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121002849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"alternative-id":["S0920121121002849"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106829","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of carbamazepine on vitamin D levels: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106829"}}